<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: following risk factors while", fill: "#adff2f"},
{source: "1: following risk factors while", target: "1: inclusive could", fill: "#adff2f"},
{source: "1: inclusive could", target: "1: individually", fill: "#adff2f"},
{source: "1: individually", target: "1: combination", fill: "#adff2f"},
{source: "1: combination", target: "1: financial condition", fill: "#adff2f"},
{source: "1: financial condition", target: "1: market price", fill: "#adff2f"},
{source: "1: market price", target: "1: common stock", fill: "#adff2f"},
{source: "1: following risk factors while", target: "7: Alternative ", fill: "#08e8de"},
{source: "7: Alternative ", target: "7: treatments", fill: "#08e8de"},
{source: "7: treatments", target: "7: services provided by", fill: "#08e8de"},
{source: "7: services provided by", target: "7: clinics alternative treatments", fill: "#08e8de"},
{source: "7: clinics alternative treatments", target: "7: patients with infertility", fill: "#08e8de"},
{source: "7: Alternative ", target: "9: disruptions", fill: "#ff43a4"},
{source: "9: disruptions", target: "9: industry relies on", fill: "#ff43a4"},
{source: "9: industry relies on", target: "9: relatively few", fill: "#ff43a4"},
{source: "9: relatively few", target: "9: manufacturers", fill: "#ff43a4"},
{source: "9: manufacturers", target: "9: specialty fertility equipment", fill: "#ff43a4"},
{source: "9: disruptions", target: "13: Thirdparty ", fill: "#c89"},
{source: "13: Thirdparty ", target: "13: significant", fill: "#c89"},
{source: "13: significant", target: "13: FertilityPartners ", fill: "#c89"},
{source: "13: Thirdparty ", target: "15: on third party vendors", fill: "#cd7f32"},
{source: "15: on third party vendors", target: "15: pharmaceutical sales", fill: "#cd7f32"},
{source: "15: pharmaceutical sales", target: "15: fertility", fill: "#cd7f32"},
{source: "15: fertility", target: "15: dependent on", fill: "#cd7f32"},
{source: "15: dependent on", target: "15: thirdparty vendors", fill: "#cd7f32"},
{source: "15: thirdparty vendors", target: "15: medications vital", fill: "#cd7f32"},
{source: "15: medications vital", target: "15: treating infertility", fill: "#cd7f32"},
{source: "15: on third party vendors", target: "16: supply shortage", fill: "#996515"},
{source: "16: supply shortage", target: "16: adverse impact on", fill: "#996515"},
{source: "16: adverse impact on", target: "16: operations", fill: "#996515"},
{source: "16: operations", target: "16: pharmaceutical sales", fill: "#996515"},
{source: "16: pharmaceutical sales", target: "16: network members", fill: "#996515"},
{source: "16: supply shortage", target: "18: State and Federal ", fill: "#ba160c"},
{source: "18: State and Federal ", target: "18: practices may", fill: "#ba160c"},
{source: "18: practices may", target: "18: State or Federal ", fill: "#ba160c"},
{source: "18: State and Federal ", target: "19: regulations", fill: "#00ced1"},
{source: "19: regulations", target: "19: AntiTrust Laws", fill: "#00ced1"},
{source: "19: regulations", target: "25: corporate practice", fill: "#1a2421"},
{source: "25: corporate practice", target: "25: medical laws vary from", fill: "#1a2421"},
{source: "25: corporate practice", target: "28: prohibit corporations", fill: "#663854"},
{source: "28: prohibit corporations", target: "28: than medical professional corporations", fill: "#663854"},
{source: "28: than medical professional corporations", target: "28: exercising control over physicians", fill: "#663854"},
{source: "28: exercising control over physicians", target: "28: may prohibit physicians from practicing medicine", fill: "#663854"},
{source: "28: may prohibit physicians from practicing medicine", target: "28: partnership with", fill: "#663854"},
{source: "28: partnership with", target: "28: practice medicine", fill: "#663854"},
{source: "28: prohibit corporations", target: "35: services provided at one", fill: "#cd5c5c"},
{source: "35: services provided at one", target: "35: fertility centers", fill: "#cd5c5c"},
{source: "35: fertility centers", target: "35: adverse effects", fill: "#cd5c5c"},
{source: "35: adverse effects", target: "35: legal proceeding", fill: "#cd5c5c"},
{source: "35: services provided at one", target: "START_HERE", fill: "#cd5c5c"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Diversified Financial Services</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Policy</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
    <tr>
      <td>Economic</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Riot</td>
    </tr>
    <tr>
      <td>Empathize</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_ratio">Financial ratio</a></td>
      <td>A financial ratio or accounting ratio is a relative magnitude of two selected numerical values taken from an enterprise's financial statements. Often used in accounting, there are many standard ratios used to try to evaluate the overall financial condition of a corporation or other organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Alternative_medicine">Alternative medicine</a></td>
      <td>Alternative medicine is any practice that aims to achieve the healing effects of medicine, but which lacks biological plausibility and is untested, untestable or proven ineffective. Complementary medicine (CM), complementary and alternative medicine (CAM), integrated medicine or integrative medicine (IM), and holistic medicine are among many rebrandings that describe various ways alternative medicine is combined with mainstream medicine.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Film_treatment">Film treatment</a></td>
      <td>A film treatment (or simply treatment) is a piece of prose, typically the step between scene cards (index cards) and the first draft of a screenplay for a motion picture, television program, or radio play. It is generally longer and more detailed than an outline (or one-page synopsis), and it may include details of directorial style that an outline omits.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_services">Financial services</a></td>
      <td>Financial services are the economic services provided by  the finance industry, which encompasses a broad range of businesses that manage money, including credit unions, banks, credit-card companies, insurance companies, accountancy companies, consumer-finance companies, stock brokerages, investment funds, individual asset managers, and some government-sponsored enterprises.\n\n\n== History ==\n\nThe term "financial services" became more prevalent in the United States partly as a result of the Gramm–Leach–Bliley Act of the late 1990s, which enabled different types of companies operating in the U.S. financial services industry at that time to merge.Companies usually have two distinct approaches to this new type of business.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Infertility">Infertility</a></td>
      <td>Fertility is the capability to produce offspring through reproduction following the onset of sexual maturity. The fertility rate is the average number of children born by a female during her lifetime and is quantified demographically.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Fertility">Fertility</a></td>
      <td>Infertility is the inability of a person, animal or plant to reproduce by natural means. It is usually not the natural state of a healthy adult, except notably among certain eusocial species (mostly haplodiploid insects).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Age_and_female_fertility">Age and female fertility</a></td>
      <td>Female fertility is affected by age and is a major fertility factor for women. A woman's fertility peaks between the late teens and late-20s, after which it starts to decline slowly.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ethics_in_pharmaceutical_sales">Ethics in pharmaceutical sales</a></td>
      <td>The ethics involved within pharmaceutical sales is built from the organizational ethics, which is a matter of system compliance, accountability and culture (Grace &amp; Cohen, 2005). Organizational ethics are used when developing the marketing and sales strategy to both the public and the healthcare profession of the strategy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_fertility_deities">List of fertility deities</a></td>
      <td>A fertility deity is a god or goddess associated with fertility, sex, pregnancy, childbirth, and crops. In some cases these deities are directly associated with these experiences; in others they are more abstract symbols.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sub-replacement_fertility">Sub-replacement fertility</a></td>
      <td>Sub-replacement fertility is a total fertility rate (TFR) that (if sustained) leads to each new generation being less populous than the older, previous one in a given area.  The United Nations Population Division defines sub-replacement fertility as any rate below approximately 2.1 children born per woman of childbearing age, but the threshold can be as high as 3.4 in some developing countries because of higher mortality rates.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Fertility_rite">Fertility rite</a></td>
      <td>The total fertility rate (TFR) of a population is the average number of children that would be born to a woman over her lifetime if:\n\nshe were to experience the exact current age-specific fertility rates (ASFRs) through her lifetime\nshe were to live from birth until the end of her reproductive life.It is obtained by summing the single-year age-specific rates at a given time. As of 2021, the total fertility rate varied from 0.81 in South Korea to 7.0 in Niger.Fertility tends to be correlated with the level of economic development.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Reproductive_endocrinology_and_infertility">Reproductive endocrinology and infertility</a></td>
      <td>Reproductive endocrinology and infertility (REI) is a surgical subspecialty of obstetrics and gynecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction as well as the issue of infertility. While most REI specialists primarily focus on the treatment of infertility, reproductive endocrinologists are trained to also test and treat hormonal dysfunctions in females and males outside infertility.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_director">Operations director</a></td>
      <td>The role of operations director generally encompasses the oversight of operational aspects of company strategy with responsibilities to ensure operation information is supplied to the chief executive and the board of directors as well as external parties.\n\n\n== Description ==\nThe role of operations director can vary according to the size of a company, and at some companies many even encompass some or all the functions of a chief operating officer.The Institute of Directors of the United Kingdom defines the role as overseeing "all operational aspects of company strategy" and "responsible for the flow of operations information to the chief executive, the board and, where necessary, external parties such as investors or financial institutions".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Evidence-based_practice">Evidence-based practice</a></td>
      <td>Evidence-based practice (EBP) is the idea that occupational practices ought to be based on scientific evidence. While seemingly obviously desirable, the proposal has been controversial, with some arguing that results may not specialize to individuals as well as traditional practices.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sati_(practice)">Sati (practice)</a></td>
      <td>Sati or suttee is a Hindu practice, now mostly historical, in which a widow sacrifices herself by sitting atop her deceased husband's funeral pyre. Greek sources from around 300 BCE make isolated mention of sati, but it probably developed into a real fire sacrifice in the medieval era within the northwestern Rajput clans to which it remained limited, to become more widespread during the late medieval era.During the early modern Mughal period, it was notably associated with elite Hindu Rajput clans in western India, marking one of the points of divergence between Hindu Rajputs and the Muslim Mughals, who banned the practice.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_ethics">Business ethics</a></td>
      <td>Business ethics (also known as corporate ethics) is a form of applied ethics or professional ethics, that examines ethical principles and moral or ethical problems that can arise in a business environment. It applies to all aspects of business conduct and is relevant to the conduct of individuals and entire organizations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Corporate_governance">Corporate governance</a></td>
      <td>Corporate governance is defined, described or delineated in diverse ways, depending on the writer's purpose. Writers focussed on a disciplinary interest or context (such as accounting, finance, law, or management) often adopt narrow definitions that appear purpose-specific.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Simpson_Thacher_&amp;_Bartlett">Simpson Thacher &amp; Bartlett</a></td>
      <td>Simpson Thacher &amp; Bartlett LLP is an international white shoe law firm headquartered in New York City. The firm specializes in litigation and corporate practices, particularly mergers and acquisitions, with over 1,000 attorneys in 11 offices worldwide.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Medical_license">Medical license</a></td>
      <td>A medical license is an occupational license that permits a person to legally practice medicine. In most countries, a person must have a medical license bestowed either by a specified government-approved professional association or a government agency before he or she can practice medicine.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Medicover_Hospitals">Medicover Hospitals</a></td>
      <td>Medicover Hospitals is a multinational hospitals chain in Europe and India. It is a part of European healthcare groups having its presence in 12 countries across the world with 26 hospitals.The Medicover group provides a broad spectrum of Health care services and has a network of hospitals, cancer institutes, specialty care facilities, Fertility Centers, and diagnostic labs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Artificial_insemination">Artificial insemination</a></td>
      <td>Artificial insemination (AI) is the deliberate introduction of sperm into a female's cervix or uterine cavity for the purpose of achieving a pregnancy through in vivo fertilization by means other than sexual intercourse or in vitro fertilisation. It is a fertility treatment for humans, and is common practice in animal breeding, including dairy cattle (see Frozen bovine semen) and pigs.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>INTEGRAMED AMERICA INC    ITEM 1A      Risk Factors    Risk Factors         The following risk factors, while not intended to be all inclusive, could  <font color="blue">individually</font> or in <font color="blue">combination</font> have a material adverse effect on our business,  <font color="blue">financial condition</font>, results of operation and <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>Competition - Our industry is <font color="blue">highly competitive</font> and subject to continual  change</td>
    </tr>
    <tr>
      <td>New <font color="blue">health care providers entering</font> the market may reduce our market  share, <font color="blue">patient volume</font> and <font color="blue">growth rates</font></td>
    </tr>
    <tr>
      <td>Additionally, <font color="blue">increased competitive</font>  <font color="blue">pressures may</font> require us to commit more resources to our <font color="blue">marketing efforts</font>,  <font color="blue">thereby increasing</font> our <font color="blue">cost structure</font> and impacting our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>There can  be no assurance that we will be able to <font color="blue">compete effectively with</font> our current  <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>Nor can there be assurance that additional <font color="blue">competitors</font> will not  enter the market, or that <font color="blue">such competition will</font> not make it more <font color="blue">difficult</font> for  us to <font color="blue">enter into</font> <font color="blue">Affiliate or <font color="blue">FertilityPartner </font></font>contracts</td>
    </tr>
    <tr>
      <td><font color="blue">Alternative </font><font color="blue">treatments</font> - In addition to the <font color="blue">services provided by</font> our  clinics, alternative <font color="blue">treatments</font> are available to <font color="blue">patients with in<font color="blue">fertility</font></font>  issues</td>
    </tr>
    <tr>
      <td>To the extent that these <font color="blue">treatments</font> are successful, or perceived as  viable <font color="blue">alternatives</font> by prospective patients, our ability to attract and retain  patients may be impacted</td>
    </tr>
    <tr>
      <td>Supply <font color="blue"><font color="blue">disruption</font>s</font> - Our <font color="blue">industry relies on</font> a <font color="blue">relatively few</font> number of  <font color="blue">manufacturers</font> of <font color="blue">specialty <font color="blue">fertility</font> equipment</font></td>
    </tr>
    <tr>
      <td>A <font color="blue"><font color="blue">disruption</font> on</font> the part of an  <font color="blue">equipment provider may</font> render the <font color="blue">medical providers within</font> our <font color="blue">network without</font>  the means to <font color="blue">treat patients</font></td>
    </tr>
    <tr>
      <td><font color="blue">Management </font>turnover - The success of our business <font color="blue">strategy depends upon</font> the  <font color="blue">continued contribution</font> of key members of our <font color="blue">management team</font></td>
    </tr>
    <tr>
      <td>The loss of key  members of this <font color="blue">team may adversely affect</font> our ability to implement that  strategy</td>
    </tr>
    <tr>
      <td>Third-party payors - A <font color="blue">significant</font> portion of our <font color="blue">FertilityPartners </font>revenue  depends upon reimbursements from third-party payors</td>
    </tr>
    <tr>
      <td><font color="blue">Disruption </font>of this  <font color="blue">relationship</font>, whether in the form of changes to <font color="blue">reimbursement contracts</font> or  <font color="blue">solvency issues on</font> the part of the payors, may lower our Service fees and  <font color="blue">therefore affect</font> our <font color="blue">cash flows</font> and <font color="blue">financial position</font></td>
    </tr>
    <tr>
      <td>Reliance <font color="blue">on third party vendors</font> - Our <font color="blue">pharmaceutical sales</font> and <font color="blue">fertility</font>  clinics are <font color="blue">dependent on</font> a limited number of third-party vendors that produce  <font color="blue">medications vital</font> to treating in<font color="blue">fertility</font></td>
    </tr>
    <tr>
      <td>Should any of these vendors  experience a <font color="blue">supply shortage</font>, it may have an <font color="blue">adverse impact on</font> the <font color="blue">operations</font> of  our <font color="blue">pharmaceutical sales</font> and our <font color="blue">network members</font></td>
    </tr>
    <tr>
      <td>To date, no shortage or  <font color="blue">disruption</font> has been experienced</td>
    </tr>
    <tr>
      <td><font color="blue">State and Federal </font>laws - Our business <font color="blue">practices may</font> be found to be in  violation of <font color="blue">State or Federal </font>laws</td>
    </tr>
    <tr>
      <td>These include, but are not limited to,  Federal and State Anti-Kickback Laws, Federal and State Self-Referral Laws,  False Claim Laws, Federal and State Controlled Substances laws, HIPAA (Health  Insurance Portability and Accountability Act) <font color="blue">regulations</font> and Anti-Trust Laws</td>
    </tr>
    <tr>
      <td>Remedial efforts could result in a <font color="blue">discontinuance</font> of portions of our business or  <font color="blue">burdensome compliance efforts</font></td>
    </tr>
    <tr>
      <td>The laws and <font color="blue">regulations</font> in this area are  <font color="blue">extremely complex</font> and subject to <font color="blue">interpretation</font> and many aspects our business  have not been the subject of federal or state <font color="blue">regulatory review</font></td>
    </tr>
    <tr>
      <td>Accordingly,  there is no assurance that our <font color="blue">operations</font> have been in <font color="blue">compliance at</font> all times  with all such laws and <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>In addition, there is no assurance that a  court or <font color="blue">regulatory authority will</font> not determine that our past, current or  future <font color="blue">operations</font> violate applicable laws or <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">operations</font> were  determined to <font color="blue">violate laws</font> or <font color="blue">regulations</font>, it could have a material adverse  effect on our business, <font color="blue">financial condition</font> and operating results</td>
    </tr>
    <tr>
      <td>In addition,  state <font color="blue">corporate practice</font> of <font color="blue">medical laws vary from</font> state to state</td>
    </tr>
    <tr>
      <td>There can be  no assurance that these laws will be interpreted in a <font color="blue">manner consistent with</font> our  practices or that other laws or <font color="blue">regulations</font> will not be enacted in the future  that could have a material adverse effect on our business, <font color="blue">financial condition</font>  and operating results</td>
    </tr>
    <tr>
      <td><font color="blue">Corporate </font>practice of medicine laws - Our <font color="blue">operations</font> may also be subject to  state laws relating to the <font color="blue">corporate practice</font> of medicine</td>
    </tr>
    <tr>
      <td>State laws may  <font color="blue">prohibit corporations</font> other <font color="blue">than <font color="blue">medical professional</font> corporations</font> or                                           9  <PAGE>    associations from practicing medicine or <font color="blue">exercising control over physicians</font>, and  <font color="blue">may prohibit physicians from practicing medicine</font> in <font color="blue">partnership with</font>, or as  employees of, any person not licensed to <font color="blue">practice medicine</font></td>
    </tr>
    <tr>
      <td>State laws may also  contain fee-splitting prohibitions or may prevent corporations from acquiring  the goodwill of a <font color="blue">medical practice</font></td>
    </tr>
    <tr>
      <td>We believe that our <font color="blue">operations</font> are in  material <font color="blue">compliance with</font> all applicable state laws relating to the corporate  practice of medicine</td>
    </tr>
    <tr>
      <td>In each <font color="blue">FertilityPartner </font> agreement, the <font color="blue">fertility</font> center is the <font color="blue">sole employer</font> of the physicians, and the  <font color="blue">fertility</font> center retains the full authority to direct the medical, professional  and <font color="blue">ethical aspects</font> of its <font color="blue">medical practice</font></td>
    </tr>
    <tr>
      <td>Liability insurance - Providing <font color="blue">health care services entails</font> a substantial  risk of <font color="blue">medical malpractice</font> and similar claims</td>
    </tr>
    <tr>
      <td>While we do not engage in the  practice of medicine, or assume <font color="blue">responsibility</font> for <font color="blue">compliance with</font> regulatory  requirements directly applicable to physicians, we do require our <font color="blue">fertility</font>  centers to maintain <font color="blue">medical malpractice</font> insurance</td>
    </tr>
    <tr>
      <td>However, in the event that  <font color="blue">services provided at one</font> of our <font color="blue">fertility</font> centers results in injury or other  <font color="blue">adverse effects</font>, we are likely to be named as a party in any <font color="blue">legal proceeding</font></td>
    </tr>
    <tr>
      <td>Although we currently maintain <font color="blue">liability insurance</font> that we believe is adequate,  <font color="blue">successful malpractice</font> claims could exceed the limits of our insurance and could  have a material adverse effect on our business</td>
    </tr>
    <tr>
      <td>Moreover, there is no assurance  that we will be able to obtain <font color="blue">such insurance on commercially reasonable terms</font>  in the future or that such insurance will provide adequate coverage against  potential claims</td>
    </tr>
    <tr>
      <td>In addition, a malpractice claim asserted <font color="blue">against us could</font> be  costly to defend, could consume management resources and <font color="blue">could adversely affect</font>  our reputation and business, regardless of the merit or <font color="blue">eventual outcome</font> of such  claim</td>
    </tr>
    <tr>
      <td>In addition, in connection with our <font color="blue">acquisition</font> of the assets of a  <font color="blue">fertility</font> centers, we may also assume some of the centerapstas liabilities</td>
    </tr>
    <tr>
      <td>Therefore, an entity may assert claims against us for events related to the  <font color="blue">fertility</font> center prior to its becoming a FertilityPartner</td>
    </tr>
    <tr>
      <td>We maintain insurance  coverage related to these risks that we believe is <font color="blue">adequate as</font> to the risks and  amounts, although there is no assurance that any successful claims will not  exceed applicable policy limits</td>
    </tr>
    <tr>
      <td>Contract termination - One or more of our <font color="blue">FertilityPartner </font><font color="blue">practices may</font>  terminate their <font color="blue">membership</font> in our network</td>
    </tr>
    <tr>
      <td>Such an occurrence would  <font color="blue">significant</font>ly reduce our revenues without a <font color="blue">corresponding</font> reduction in our cost  structure</td>
    </tr>
    <tr>
      <td>Physician <font color="blue">resignation</font> - The <font color="blue">departure</font> of one or more <font color="blue">key medical providers</font>  <font color="blue">may negatively impact</font> the ability of our <font color="blue">FertilityPartners </font>to generate  sufficient revenues</td>
    </tr>
    <tr>
      <td>A reduction in <font color="blue">FertilityPartner </font><font color="blue">revenue would reduce</font> our  revenues and may require us to <font color="blue">advance funds</font> to the <font color="blue">fertility</font> center</td>
    </tr>
    <tr>
      <td><font color="blue">Technology </font>risks - The treatment of in<font color="blue">fertility</font> is a <font color="blue">technologically</font>  intensive area of medicine</td>
    </tr>
    <tr>
      <td><font color="blue">Financial </font>results - Our quarterly results and <font color="blue">stock price may fluctuate</font>  over time <font color="blue">based on</font> our business risk factors, seasonal influences, market  <font color="blue">expectations</font> or other <font color="blue">factors over which</font> we have limited control</td>
    </tr>
    <tr>
      <td>In addition  changes to <font color="blue">financial variables over which</font> we do exercise some control, such as  dividend policy, stock dilution, banking and credit facilities, etc, may be  perceived <font color="blue">differently by different stakeholders</font>, and <font color="blue">thereby influence</font> our stock  price</td>
    </tr>
  </tbody>
</table>